CJI (Traditional Chinese Medicine)

养血清脑颗粒辅助西药­对脑供血不足患者血栓­前状态及内皮细胞功能­的影响

-

李晓宁1,顾乃兵 2 1.核工业二一五医院,陕西 咸阳 712000;2.西安市中心医院,陕西 西安 710000

摘要:目的 探讨养血清脑颗粒辅助­西药对脑供血不足患者­血栓前状态及内皮细胞­功能的影响。方法 将

200例脑供血不足患­者随机分为观察组及对­照组各100例。对照组予盐酸倍他司汀­氯化钠注射液20 mg,每日

1次,静脉滴注;治疗组在对照组基础上­予养血清脑颗粒,每次4 g(首量加倍),每日3次,冲服。2组均连续治疗 3 个月。观察 2 组治疗前后血浆纤溶酶­原激活物抑制剂-1(PAI-l)、组织纤维溶酶原激活物(t-PA)及

内皮依赖性舒张功能(EED)、一氧化氮(NO)、内皮素(ET-1)水平,评价临床疗效。结果 观察组总有效率为 85%(85/100),对照组为 72%(72/100),观察组明显优于对照组(P<0.05)。与本组治疗前比较,2 组PAI-l、ET-l 水平明显下降,t-PA、EED、NO 水平明显升高,差异有统计学意义(P<0.05);2组治疗后比较,观察组 PAI-l、ET-l 水平低于对照组,t-PA、EED、NO 水平高于对照组,差异有统计学意义(P<0.05)。PAI-l、ET-l 水平降低及 t-PA、EED、NO 水平升高与患者症状改­善密切相关(P<0.05)。结论 养血清脑颗粒辅助西药­可改善脑供血不足患者­血栓前状态及内皮细胞­功能,改善慢性脑供血不足,疗效显著。关键词:养血清脑颗粒;脑血管供血不足;血栓前状态;内皮功能

DOI:10.3969/j.issn.1005-5304.2018.12.005

中图分类号:R277.73 文献标识码:A 文章编号:1005-5304(2018)12-0015-04

Effects of Yangxue Qingnao Granules Combined with Western Medicine on Prethrombo­tic State and Endotheliu­m in Patients with Cerebral Vascular Insufficie­ncy

LI Xiao-ning1, GU Nai-bing2

1. 215 Hospital of Nuclear Industry, Xianyang 712000, China; 2. Xi’an Central Hospital, Xi’an 710000, China Abstract: Objective To investigat­e the effects of Yangxue Qingnao Granules combined with Western medicine on prethrombo­tic state and endotheliu­m in patients with cerebral vascular insufficie­ncy. Methods Totally 200 patients with cerebral vascular insufficie­ncy were randomly divided into observatio­n group and control group, with 100 cases in each group. The control group was given betahistin­e hydrochlor­ide sodium chloride injection 20 mg, once a day, intravenou­s drip. The observatio­n group was given Yangxue Qingnao Granules on the basis of the control group, 4 g each time (doubling the amount for the first time), three times a day, take after mixing it with water. The treatment for both groups lasted for three months. Plasma plasminoge­n activator inhibitor-1 (PAI-1), tissue plasminoge­n activator (t-PA) and endotheliu­m-dependent dilation (EED), nitric oxide (NO) and endothelin (ET-1) were observed before and after treatment, and clinical efficacy was evaluated. Results The total effective rate was 85% (85/100) in the observatio­n group and 72% (72/100) in the control group. The observatio­n group was significan­tly better than the control group (P<0.05). Compared with before treatment, the levels of PAI-l and ET-1 decreased significan­tly, and the levels of t-PA, EED and NO increased significan­tly, with statistica­l significan­ce (P<0.05). After treatment, the levels of PAI-l and ET-1 in the observatio­n group were lower than those in the control group, and the levels of t-PA, EED and NO were higher than those in the control group, with statistica­l significan­ce (P<0.05). The levels of PAI-l and

ET-1 decreased, and the levels of t-PA, EED and NO increased, which were closely related to the improvemen­t of patients' symptoms (P<0.05). Conclusion Yangxue Qingnao Granules combined with Western medicine can improve prethrombo­tic state and endothelia­l cell function in patients with cerebral vascular insufficie­ncy, improve chronic cerebral blood supply insufficie­ncy, and has remarkable curative effect.

Keywords: Yangxue Qingnao Granules; cerebral vascular insufficie­ncy; prethrombo­tic state; endothelia­l function

Newspapers in Chinese (Simplified)

Newspapers from China